α6-Integrin Subunit Plays a Major Role in the Proangiogenic Properties of Endothelial Progenitor Cells

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 30; no. 8; pp. 1569 - 1575
• Main Authors: Bouvard, Claire, Gafsou, Benjamin, Dizier, Blandine, Galy-Fauroux, Isabelle, Lokajczyk, Anna, Boisson-Vidal, Catherine, Fischer, Anne-Marie, Helley, Dominique
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Heart Association, Inc 01.08.2010; Lippincott Williams & Wilkins
• Subjects: Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Blood and lymphatic vessels; Blood vessels and receptors; Cardiology. Vascular system; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Fundamental and applied biological sciences. Psychology; Medical sciences; Vertebrates: cardiovascular system; Endothelial cell; Cardiovascular disease; peripheral arterial disease; vascular biology; Arterial disease; Vascular disease; Angiogenesis; Integrin; Ischemia; adhesion molecules; Atherosclerosis; Occlusive arterial disease; Progenitor cell
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/ATVBAHA.110.209163

OBJECTIVE—Alpha6 integrin subunit (α6) expression is increased by proangiogenic growth factors such as vascular endothelial growth factor (VEGF) and fibroblast growth factor. This increase correlates with enhanced in vitro tube formation by endothelial cells and their progenitors called Endothelial Colony-Forming Cells (ECFCs). We thus studied the role of α6 in vasculogenesis induced by human ECFCs, in a mouse model of hindlimb ischemia. METHODS AND RESULTS—We used small interfering RNA (siRNA) to inhibit α6 expression on the surface of ECFCs. For in vivo studies, human ECFCs were injected intravenously into a nude mouse model of unilateral hind limb ischemia. Transfection with siRNA α6 abrogated neovessel formation and reperfusion of the ischemic hind limb induced by ECFCs (P<0.01 and P<0.001, respectively). It also inhibited ECFC incorporation into the vasculature of the ischemic muscle (P<0.001). In vitro, siRNA α6 inhibited ECFC adhesion (P<0.01), pseudotube formation on Matrigel, migration, and AKT phosphorylation (P<0.0001), with no effect on cell proliferation or apoptosis. CONCLUSION—α6 Expression is required for ECFC migration, adhesion, recruitment at the site of ischemia, and the promotion of the postischemic vascular repair. Thus, we have demonstrated a major role of α6 in the proangiogenic properties of ECFCs.